U.S. Biotech Stock News

Interface (TILE) has quietly put up a strong year, with shares gaining about 16% year to date and revenue and net income both growing around 5%, which is drawing fresh attention. See our latest analysis for Interface. With the share price now around $27.79 and a solid year to date share price return backing it up, Interface’s 5 year total shareholder return of over 200% suggests momentum has largely been a long term story rather than a recent surge. If Interface’s steady climb has you...

Rivian recently outlined plans to cut material costs by 45% with its Gen 2 platform by 2026, target positive adjusted EBITDA by 2027, and expand production capacity by 400,000 vehicles at a new Georgia plant, while its CEO RJ Scaringe sold more than 17,450 shares and received a new performance-linked compensation package potentially worth up to US$4.60 billion. The combination of ambitious long-term margin and free cash flow targets with a Tesla-style CEO pay plan tightly tied to profit and...

Everest Group (EG) just reshuffled a key piece of its leadership, naming veteran finance executive Elias Habayeb as its next Chief Financial Officer, a move that subtly reframes the stock’s long term story. See our latest analysis for Everest Group. The CFO transition comes after a choppy stretch for Everest Group, with a roughly double digit 3 month share price return decline and a softer year to date move. However, the 5 year total shareholder return remains solidly positive, suggesting...

Align Technology (ALGN) just gave investors a fresh data point to chew on by rolling out its Invisalign System with mandibular advancement in the Philippines, and the stock quickly climbed about 6% on the news. See our latest analysis for Align Technology. The upbeat reaction to the Philippines launch sits against a tougher backdrop, with a roughly 9% one month share price return, but a year to date share price return still down about 28%, and a one year total shareholder return of around...

If you are wondering whether Ensign Group remains attractive after its recent run, or if you are arriving just as the value is fading, this breakdown aims to provide a clear, grounded view of what the stock may be worth. The share price has pulled back slightly in the short term, down 3.1% over the last week and 1.5% over the last month. It is still up 36.3% year to date and 24.6% over the past year, with gains of 97.9% over 3 years and 141.4% over 5 years that indicate a strong long-term...

Toast (TOST) is back in the spotlight after BNP Paribas Exane bumped the stock up to an Outperform rating, just as the company leans into AI driven restaurant tools and steadier margin improvement. See our latest analysis for Toast. Even after a choppy few months and a roughly 7 percent year to date share price decline, Toast’s three year total shareholder return of about 96 percent suggests the longer term growth story is still very much intact. Recent AI focused upgrades also hint that...

VinFast Auto recently reported its third-quarter and nine-month 2025 results, with revenue rising to ₫18,100,218 million and ₫51,015,903 million respectively, while net losses also increased to ₫23,952,814 million for the quarter and ₫61,940,691 million for the nine-month period. The company also added senior executive Pham Nhat Quan Anh to its Board of Directors, reinforcing board-level expertise in global operations and quality oversight. Next, we’ll examine how higher revenue but larger...

ResMed recently saw Richard Sulpizio step down from its board and filed two employee stock ownership-related shelf registrations totaling about US$1.32 billion in common stock, while Goldman Sachs removed the company from its APAC Conviction List. Together, these moves highlight a mix of ordinary corporate housekeeping and a meaningful reassessment by a major broker that could reshape how investors view ResMed’s prospects. Next, we’ll explore how Goldman Sachs’ decision to drop ResMed from...

Synopsys (SNPS) has been grinding through a tricky stretch, with the stock sliding over the past 3 months even as revenue and net income keep growing at a double digit clip. See our latest analysis for Synopsys. Despite the recent 90 day share price return of minus 25.35 percent, Synopsys still sits on a solid 3 year total shareholder return of 38.77 percent. This suggests longer term momentum has cooled rather than disappeared. If Synopsys has you rethinking your tech exposure, it could be a...

As December 2025 unfolds, the U.S. stock market is experiencing a rebound with major indexes like the tech-heavy Nasdaq, blue-chip Dow Jones Industrial Average, and benchmark S&P 500 posting gains amid renewed investor confidence in tech and crypto-related stocks. In this dynamic environment, identifying promising small-cap stocks requires a keen understanding of market trends and insider actions that may signal potential opportunities for growth.

As of December 2025, the United States market has shown resilience with major indexes like the tech-heavy Nasdaq and blue-chip Dow Jones Industrial Average closing higher, fueled by a rebound in tech and crypto-related stocks. In this environment of renewed optimism, identifying high-growth tech stocks involves looking for companies that not only demonstrate robust financial performance but also have the potential to capitalize on emerging trends and technological advancements within a...

As of early December 2025, U.S. markets have shown resilience with major indexes closing higher amid a rebound in tech and crypto-related stocks. This environment presents opportunities for investors to explore stocks that may be trading below their fair value estimates, such as Lyft and others, by focusing on fundamental strengths and market positioning amidst the current economic landscape.

Astera Labs, Inc. has announced the expansion of its connectivity solutions with a focus on custom offerings to support the growing complexity of next-generation AI infrastructure. By leveraging NVIDIA's NVLink Fusion ecosystem, Astera Labs aims to provide hyperscalers with custom solutions to optimize performance, energy efficiency, and cost for varied AI workloads. The company's initiative highlights the need for tailored connectivity in heterogeneous systems, enabling infrastructure...

As the U.S. markets rebound with tech and crypto-related stocks leading the charge, investors are keenly observing growth companies that demonstrate robust insider ownership and impressive revenue trajectories. In this environment, firms showcasing significant insider stakes alongside strong revenue growth often signal confidence in their business models and potential resilience amid fluctuating market conditions.

As the U.S. markets close higher with a rebound in tech and crypto-related stocks, investors are keenly observing opportunities across various sectors. Penny stocks, despite being an older term, continue to hold relevance for those seeking growth potential in smaller or newer companies. These stocks can offer significant returns when backed by strong financial health, making them an intriguing option for investors looking to uncover hidden value in quality companies.

As the United States markets experience a rebound, with major indexes such as the Nasdaq, Dow Jones Industrial Average, and S&P 500 closing higher amid a resurgence in tech and crypto-related stocks, investors are keenly observing opportunities for stable returns. In this environment of fluctuating market dynamics, dividend stocks offer potential appeal by providing consistent income streams; here we explore three dividend stocks with yields ranging up to 8%.

We'd be surprised if Arrowhead Pharmaceuticals, Inc. ( NASDAQ:ARWR ) shareholders haven't noticed that the Independent...

Motorcar Parts of America, Inc. ( NASDAQ:MPAA ) shareholders won't be pleased to see that the share price has had a...

Harte Hanks, Inc. ( NASDAQ:HHS ) shares have had a really impressive month, gaining 25% after a shaky period...

Prelude Therapeutics Incorporated ( NASDAQ:PRLD ) shares have retraced a considerable 66% in the last month, reversing...

Despite an already strong run, Steven Madden, Ltd. ( NASDAQ:SHOO ) shares have been powering on, with a gain of 27% in...

Xeris Biopharma Holdings, Inc. ( NASDAQ:XERS ) shares have had a horrible month, losing 35% after a relatively good...

Allegiant Travel Company ( NASDAQ:ALGT ) shareholders have had their patience rewarded with a 25% share price jump in...

Some Howard Hughes Holdings Inc. ( NYSE:HHH ) shareholders may be a little concerned to see that the Independent...